Elucidation of the molecular mechanism of Cas-endonucleases from bacteria and cyanobacteria
Elucidation of the molecular mechanism of Cas-endonucleases from bacteria and cyanobacteria
批准号:
405856574
负责人:
Dr. Sabine Schneider
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2018
资助国家:
德国
项目状态:
已结题
起止时间:
2017-12-31 至 2021-12-31
中文摘要
CRISPR-Cas系统(CRISPR = Clustered Regulatory Interspaced Short Palindromic Repeats, Cas= CRISPR相关基因)被原核生物用来防御噬菌体、入侵的核酸和可移动的遗传元件。这些适应性免疫系统由基因组crispr基因座和一个(或一个复杂的)效应核酸酶组成,该基因座在crRNA (CRISPR-RNA)中转录,以crRNA序列依赖的方式切割目标核酸。由化脓性链球菌(SpyCas9)的Cas9内切酶在rna引导下,序列依赖的双链DNA切割目前被用于多种生物的位点特异性基因组修饰,并彻底改变了生物学领域。通过破译spycas9系统的分子机制,结构生物学在设计和利用spycas9系统作为通用基因组编辑工具方面发挥了至关重要的作用。到目前为止,已经确定了大约100种cas蛋白和crispr相关蛋白的结构。然而,原核生物和古细菌拥有大量的、高度多样化的cas系统,迄今为止,这些系统的自然功能和作用机制尚不清楚,还有大量这样的系统有待发现。基于细菌和古细菌基因组的生物信息学分析,预测并分类了细菌、古细菌和蓝藻中许多新的cas蛋白亚型。此外,最近的研究表明,一个活跃的1类CRISPR-Cas系统产生低聚腺苷酸二级信使,导致另一种内切酶的激活和rna降解。此外,目前的数据表明,CRISPR-Cas系统不仅是原核防御机制,还在DNA修复、基因表达调控、毒力和水平基因转移等方面发挥作用。这清楚地强调,尽管在描述这些有趣的系统方面已经取得了巨大的进展,但关于它们在自然生物体中的分子机制和功能的许多信息在很大程度上是缺失的。我的课题组主要研究核酸的结构-功能关系以及蛋白质因子和小分子对核酸的识别。在这个拟议的项目中,我们希望从蓝藻和细菌中生物化学和结构上表征2类cas蛋白。这将导致这些细菌和蓝藻cas蛋白的分子机制的详细阐明。为了全面了解原子的细节及其在自然宿主中的功能,我们将在本提案中概述的这一优先计划框架内与G. Bange、W. Hess、G. Klug和a . Marchfelder小组合作。在资助期内,优先项目的成员可能会发现在其自然生物体中具有特殊作用的新型Cas-和Cas相关蛋白。在这里,我们将能够发挥我们的专业知识,并破译这些蛋白质的分子机制。
英文摘要
CRISPR-Cas systems (CRISPR = Clustered Regulatory Interspaced Short Palindromic Repeats, Cas= CRISPR-associated gene) are used by prokaryotes to defend themselves against phages, invading nucleic acids and mobile genetic elements. These adaptive immune systems consist of a genomic CRISPR-locus, which is transcribed in the crRNA (CRISPR-RNA) and one (or a complex) effector nuclease, that cleaves the target nucleic acid in a crRNA-sequence dependent manner. The RNA-guided, sequence-dependent cleavage of double stranded DNA by the Cas9 endonuclease of Streptococcus pyogenes (SpyCas9) is currently exploited for the site-specific genome modification of various organisms and has revolutionised the field of biology. Structural biology played a crucial role to engineer and harness the SpyCas9-system as a universal genome editing tool by deciphering its molecular mechanism. About 100 structures of Cas-proteins and CRISPR-associated proteins have been determined by now. However, prokaryotes and archaea possess numerous, highly diverse Cas-systems, with to date unknown natural functions and mechanisms of action as well as a large number of such systems still remaining to be discovered. Based on bioinformatics analysis of bacterial and archaeal genomes, many novel subtypes of Cas-proteins were predicted and classified in bacteria, archaea and cyanobacteria. Furthermore, recent studies show that an active Class 1 CRISPR-Cas system generates oligoadenylate secondary messengers, resulting in the activation of another endonuclease and RNA-degradation. In addition, current data suggest that CRISPR-Cas systems are not merely prokaryotic defence mechanisms, but also play a role in DNA repair, regulation of gene expression, virulence and horizontal gene transfer. This clearly emphasis that despite the tremendous progress in the characterisation of these intriguing systems which has already been made, a lot of information on their molecular mechanisms and functions in the natural organisms is largely missing. My research group focuses on the structure-function relationship of nucleic acids and their recognition by protein factors and small molecules. In this proposed project we want to biochemically and structurally characterise Class 2 Cas-proteins from cyanobacteria and bacteria. This will lead to a detailed elucidation of the molecular mechanisms of these bacterial and cyanobacterial Cas-proteins. In order to obtain a full picture of the atomic details and their function in the natural host, we will cooperate with the groups of G. Bange, W. Hess, G. Klug and A. Marchfelder within the framework of this priority program as outlined in the present proposal. Within the funding period novel Cas- and Cas-associated proteins with particular roles in their natural organisms might be discovered by members of the priority program. Here we will be able to bring our expertise into play and to decipher the molecular mechanisms of these proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional and structural characterization of regulatory nucleic acids and functionalization of protein in Bacilus subtilis
-
批准号:456708124
-
项目类别:Heisenberg Grants
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Dr. Sabine Schneider
-
依托单位:
Chemical proteomic strategies for deciphering neocarzilin´s mode of action in cancer cells
-
批准号:426512676
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Dr. Sabine Schneider
-
依托单位:
Functional and structural characterization of regulatory nucleic acids and functionalization of protein in Bacilus subtilis
-
批准号:388174883
-
项目类别:Heisenberg Fellowships
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Dr. Sabine Schneider
-
依托单位:
Inositol as a regulator of seedling development
-
批准号:242751175
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Dr. Sabine Schneider
-
依托单位:
Strategie zur Identifizierung zyklischer Peptide als selektive Inhibitoren von RNA-Protein-Wechselwirkungen zur antibakteriellen Therapie
-
批准号:211611392
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Dr. Sabine Schneider
-
依托单位:
Molecular mechanisms and roles of the mammalian 2-oxoglutarate-dependent oxygenases AlkBH1 and AlkBH7
-
批准号:442081128
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Dr. Sabine Schneider
-
依托单位:
国内基金
海外基金
登录
查看更多内容
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
-
批准号:82372073
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张淼
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
-
批准号:82372328
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:项盈
-
依托单位:
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
-
批准号:82304565
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李瑾
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
Irisin通过整合素调控黄河鲤肌纤维发育的分子机制研究
-
批准号:32303019
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:职韶阳
-
依托单位:
上皮细胞黏着结构半桥粒在热激保护中的作用机制研究
-
批准号:31900545
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:傅容
-
依托单位: